Publication | Closed Access

Avoiding bevacizumab related gastrointestinal toxicity for recurrent ovarian cancer by careful patient screening

Gastrointestinal OncologyMedicineCancer ManagementGastroenterologyGynecologyRecurrent Ovarian CancerGastrointestinal ToxicityCancer TreatmentCareful Patient ScreeningOncologyRadiation OncologyGynecology OncologyOvarian Cancer